Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001172661-25-001269·60 DEGREES PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
60 DEGREES PHARMACEUTICALS I
Common Stock, par value $0.0001 · CUSIP: 83006G203
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Armistice Capital, LLC
Shares: 476,866.00 · Class: 9.99%
- Steven Boyd
Shares: 476,866.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-001269
- Form type
- SCHEDULE 13G/A
- Filer
- 60 DEGREES PHARMACEUTICALS, INC.
- CIK
- CIK 1946563
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership